This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sanofi SA (SNY)

NYSE: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 5.34B 5.13B 6.57B 0.00
Operating Gains/Losses 32.83M -479.16M -113.74M -44.07M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -27.97M 241.65M 486.68M -333.10M
(Increase) Decrease in Inventories -13.38M -161.56M -588.52M -300.69M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 581.25M -171.23M 88.61M -112.76M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 623.81M 277.56M -425.85M 79.06M
Other Non-Cash Items -232.26M -1.53B -488.00M 8.20B
Net Cash From Continuing Operations 9.35B 9.60B 10.81B 12.27B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 9.35B 9.60B 10.81B 12.27B
Sale of Property, Plant & Equipment 327.11M 564.78M 473.46M 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -1.89B -1.93B -2.13B -2.31B
Acquisitions 0.00 -324.50M -372.95M -17.61B
Purchases of Short-Term Investments -694.34M -24.86M -60.84M -33.70M
Other Cash from Investing Activities 150.79M -42.81M -6.61M 903.38M
Cash Provided by Financing Activities
Net Cash From Investing Activities -4.21B -1.76B -2.10B -19.05B
Issuance of Debt 3.62B 4.31B 1.56B 10.83B
Cash Used for Financing Activities
Issuance of Capital Stock 828.10M 1.39B 854.34M 94.61M
Repayment of Long-Term Debt -3.69B -3.90B -1.78B -3.80B
Repurchase of Capital Stock -2.19B -2.27B -1.09B -1.39B
Payment of Cash Dividends -4.48B -5.04B -13.23M -1.80B
Other Financing Charges, Net -391.56M 361.79M -5.29B -187.93M
Net Cash From Financing Activities -6.30B -5.15B -5.75B 3.75B
Effect of Exchange Rate Changes 41.34M -109.09M 31.74M 1.30M
Net Change in Cash & Cash Equivalents -1.11B 2.59B 2.98B -3.03B
SNY News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for SNY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

SNY Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs